Aurinia Pharm Ord (AUPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 73,189 | 53,002 | 66,428 | 83,433 | 37,142 |
| Marketable Securities | 278,619 | 262,131 | 246,473 | 275,043 | 311,605 |
| Receivables | 30,728 | 40,091 | 40,350 | 36,544 | 36,483 |
| Inventories | 44,793 | 46,503 | 46,195 | 39,228 | 38,714 |
| Other current assets | 301 | 665 | 781 | 1,129 | 2,700 |
| TOTAL | $438,737 | $408,970 | $405,762 | $446,596 | $440,459 |
| Non-Current Assets | |||||
| PPE Net | 2,266 | 2,421 | 2,576 | 2,731 | 2,887 |
| Intangibles | 3,901 | 4,046 | 4,158 | 4,355 | 4,509 |
| Other Non-Current Assets | 82,624 | 87,125 | 92,354 | 96,963 | 101,506 |
| TOTAL | $88,791 | $93,592 | $99,088 | $104,049 | $108,902 |
| Total Assets | $527,528 | $502,562 | $504,850 | $550,645 | $549,361 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,214 | 3,312 | 4,220 | 5,187 | 56,770 |
| Accrued Expenses | 49,536 | 49,704 | 42,353 | 64,971 | N/A |
| Other current liabilities | 2,502 | 2,537 | 1,695 | 1,531 | 1,590 |
| TOTAL | $76,220 | $78,266 | $68,406 | $97,763 | $78,609 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 4,602 | 5,499 | 4,594 | 11,002 | 4,304 |
| Other Non-Current Liabilities | 17,561 | 17,364 | 16,976 | 15,151 | 16,795 |
| TOTAL | $85,537 | $88,995 | $86,254 | $75,404 | $82,750 |
| Total Liabilities | $161,757 | $167,261 | $154,660 | $173,167 | $161,359 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 131,841 | 131,630 | 135,104 | 137,339 | 143,179 |
| Common Shares | 1,116,797 | 1,122,582 | 1,163,262 | 1,187,696 | 1,206,613 |
| Retained earnings | -860,162 | -891,713 | -913,226 | -936,570 | -937,999 |
| Other shareholders' equity | -749 | -905 | -825 | -647 | -385 |
| TOTAL | $365,771 | $335,301 | $350,190 | $377,478 | $388,002 |
| Total Liabilities And Equity | $527,528 | $502,562 | $504,850 | $550,645 | $549,361 |